Sally Coulter Selected Research

Non-alcoholic Fatty Liver Disease

1/2020	Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.
1/2020	Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
6/2013	Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sally Coulter Research Topics

Disease

5	Cholestasis 01/2018 - 09/2003
4	Liver Diseases (Liver Disease) 09/2022 - 02/2005
4	Fibrosis (Cirrhosis) 01/2020 - 04/2013
3	Non-alcoholic Fatty Liver Disease 01/2020 - 06/2013
3	Critical Illness (Critically Ill) 07/2014 - 11/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 04/2013
2	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2016
2	Hot Flashes 08/2019 - 01/2016
1	Hepatitis B 09/2022
1	Fatty Liver 01/2020
1	Alcoholic Hepatitis 01/2018
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2018
1	End Stage Liver Disease 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2017
1	Inflammation (Inflammations) 02/2015
1	Weight Gain 02/2015
1	Hyperbilirubinemia 11/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2005
1	Acute Kidney Injury (Acute Renal Failure) 02/2005

Drug/Important Bio-Agent (IBA)

13	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 09/2003
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020 - 01/2018
3	BilirubinIBA 01/2018 - 09/2003
2	Tamoxifen FDA LinkGeneric 08/2019 - 01/2016
2	4-hydroxy-N-desmethyltamoxifenIBA 08/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2003
2	CholesterolIBA 02/2015 - 02/2005
2	LigandsIBA 04/2013 - 02/2005
1	Circular DNAIBA 09/2022
1	Antiviral Agents (Antivirals)IBA 09/2022
1	SodiumIBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	TransferasesIBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Taurine FDA Link 01/2018
1	Cholic AcidIBA 01/2018
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2018
1	Sunitinib (Sutent)FDA Link 08/2017
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Triglycerides (Triacylglycerol)IBA 02/2015
1	AdiponectinIBA 06/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2011
1	Pregnane X ReceptorIBA 07/2006
1	OxysterolsIBA 02/2005
1	CholestanolsIBA 02/2005
1	Dietary CholesterolIBA 02/2005
1	Cytochrome P-450 CYP3AIBA 03/2004
1	multidrug resistance-associated protein 1IBA 09/2003
1	Proteins (Proteins, Gene)FDA Link 09/2003
1	Messenger RNA (mRNA)IBA 09/2003
1	Growth Hormone (Somatotropin)IBA 09/2003
1	AnionsIBA 09/2003
1	bile acid binding proteinsIBA 09/2003
1	Interleukin-6 (Interleukin 6)IBA 09/2003
1	EndotoxinsIBA 09/2003
1	Peptides (Polypeptides)IBA 09/2003

Therapy/Procedure

5	Therapeutics 09/2022 - 04/2013
2	Parenteral Nutrition 07/2014 - 01/2014
1	Drug Tapering 08/2019
1	Drug Therapy (Chemotherapy) 08/2019
1	Ligation 03/2004